EP3698796
PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS
:
EP einkaleyfi: Þýðing ekki lögð inn:
28.9.2017:
27.10.2021:
20165564.4
:
27.9.2037
:
PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS
28.9.2017
27.10.2021
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
CASAREZ, Anthony:
Emeryville, CA 94608, US
:
FUREGATI, Markus:
4002 Basel, CH
:
KOCH, Guido:
4002 Basel, CH
:
LIN, Xiaodong:
Emeryville, CA 94608, US
:
OSSOLA, Flavio:
4002 Basel, CH
:
RECK, Folkert:
Emeryville, CA 94608, US
:
SIMMONS, Robert Lowell:
Emeryville, CA C94608, US
:
ZHU, Qingming:
Emeryville, CA 94608, US
:
201662401022 P:
28.9.2016:
US
:
C07D 471/18, A61K 31/407, A61P 31/04, A61K 31/427, A61K 31/431, A61K 31/496, A61K 31/546, A61K 31/551, A61K 45/06